Home / Recalls / Golden State Medical Supply Inc. / D-0276-2024

D-0276-2024 Class II Terminated

Recalled by Golden State Medical Supply Inc. — Camarillo, CA

Recall Details

Product Type
Drugs
Report Date
February 7, 2024
Initiation Date
January 12, 2024
Termination Date
March 20, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
108 bottles

Product Description

Budesonide Extended-Release Tablets, 9 mg, 30-count bottles, Rx only, Marketed by: GSMS, Incorporated, Camarillo, CA, UPC 5140782430, NDC 51407-824-30

Reason for Recall

Failed Dissolution Specifications

Distribution Pattern

Illinois only

Code Information

Lot #: GS054862, Exp. Date 07/31/2025

Other recalls by Golden State Medical Supply Inc.

  • D-0235-2026 Class II — Baclofen Tablets USP, 10 mg, 1000-count bottles, Rx only, Marketed by: GSMS, Inc (November 26, 2025)
  • D-0158-2026 Class II — NIACIN Extended-Release Tablets, USP, 1,000 mg, 90 tablets per bottle, Rx only, (October 20, 2025)
  • D-0287-2025 Class II — PRASUGREL TABLETS, 5 mg, 30 tablet bottles, Rx only, packaged by GSMS, Incorpora (March 5, 2025)
  • D-0568-2024 Class II — Duloxetine Delayed-Release Capsules, USP, 30mg, Rx Only, a) 30 capsules bottles, (May 13, 2024)
  • D-0349-2024 Class II — Fluticasone Propionate Nasal Spray USP, 50 mcg per spray, 120 metered sprays, 16 (February 14, 2024)
  • D-0129-2024 Class II — PAROXETINE tablets, USP, 20 mg, Packaged as a) 90-count bottle NDC 60429-735-90; (November 10, 2023)
  • D-0128-2024 Class II — PAROXETINE tablets, USP, 10 mg, Packaged as a) 30-count bottle, NDC 60429-734-3 (November 10, 2023)
  • D-0130-2024 Class II — PAROXETINE tablets, USP, 40 mg, Packaged as a) 30-count bottle, NDC 60429-737-3 (November 10, 2023)
  • D-0867-2023 Class II — Travoprost Ophthalmic Solution, USP (Ionic Buffered Solution), 0.004%, Rx only, (May 25, 2023)
  • D-0011-2023 Class II — Rifampin Capsules, USP, 300 mg, packaged in a) 30-count bottle (NDC 51407-323-30 (October 6, 2022)